MATINAS BIOPHARMA HOLDINGS, INC.
Asset & Liabilities Breakdown
Asset Breakdown FY2020
Total Assets: $71.0M
Liabilities Breakdown FY2020
Total Liabilities: $7.2M
Asset Breakdown
Total Assets: $71.0M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $12.4M | 17.5% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $1.5M | 2.1% |
| Goodwill | $1.3M | 1.9% |
| Intangible Assets | $3.0M | 4.3% |
| Other Assets | $52.7M | 74.2% |
Liabilities Breakdown
Total Liabilities: $7.2M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $349.9K | 4.8% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $6.9M | 95.2% |